Editorial
Aditya Grover, Anjali Hirani a
Abstract
Numerous deaths are caused every year by the morbidity of brain disorders, namely gliomas. The staggering number of deaths may be contributed by the anatomic blood-brain barrier, restricting access to a number of therapeutic compounds. This article briefly describes the blood-brain barrier and the current state of nanoparticle therapeutics that aim to cross the blood-brain barrier to improve drug delivery to this highly sensitive region.